Elisa Espinet

13PUBLICATIONS
113CO-AUTHORS
Molecular targetsPredictive and prognostic markersChemical and thermal processes in energy and combustionPharmaceutical delivery technologiesCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 16, 2026
Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression.

|Mar 09, 2026
Molecular subtypes in pancreatic cancer: from academic promise to clinical reality.

Daniela Mercedes D'Empaire Altimari, Michele Bevere, Elisa Espinet

|Feb 23, 2026
Epigenetic dysregulation of IRF9 drives excessive interferon signaling in COPD.

Maria Llamazares-Prada, Uwe Schwartz, Darius F Pease

|Feb 20, 2025
Site-specific activation of the proton pump inhibitor rabeprazole by tetrathiolate zinc centres.

Teresa Marker, Raphael R Steimbach, Cecilia Perez-Borrajero

|Jan 06, 2025
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response in pancreatic cancer.

Lukas Klein, Mengyu Tu, Niklas Krebs

|Jul 12, 2023
LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma.

Hamed Alborzinia, Zhiyi Chen, Umut Yildiz

Pageof 3

Frequent Collaborators

7 joint publications

Andreas Trumpp

2 joint publications

Charles D Imbusch

2 joint publications

Argyris Papantonis

2 joint publications

Elisa Donato